http://rdf.ncbi.nlm.nih.gov/pubchem/patent/NO-168478-B

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bb75b0b19820e3833ebdcb31603b242b
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02P20-55
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D339-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C323-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D241-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C309-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D505-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-5352
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-535
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D505-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D519-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N43-90
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-535
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D339-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D241-08
filingDate 1983-09-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_af6fc8783b37889a2983c5922699f9c1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5e393ac3df83b091b79e63ca2055395c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_330ca680c0092a44f0ffb8ef5595d687
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_358c426052e30d88c804d73b6415eff4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9964733fc21c6ee0d379861f16996260
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bee91444938988e572856c74af1ae334
publicationDate 1991-11-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber NO-168478-B
titleOfInvention ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE VINYLTHIOACETAMIDO-OXACEPHALOSPORINE DERIVATIVES.
abstract New, therapeutically effective vinylthio-acetamido-oxacephalosporin derivatives with it. general formula :. wherein u is hydrogen, carboxamido, N-hydroxy-carboxamido, carboxy, azido, aryl, acylamino ,. protected carboxy or N-alkoxycarboxamido ,. or may together with v be -S- or -CHS- ;. v is hydrogen, halogen, cyano or alkylthio ,. or may together with be -S- or -CHS-,. or may together with w be - (CH 2) CO-; w er. hydrogen, carbamoyl, cyano, carboxy, N-alkyl-carbamoyl, alkyl, aryl, protected carboxy or. a heterocyclic group, or may together with. v be - (CH) CO-; x is halogen, trlfluoromethyl ,. alkylthio or arylthio; y is hydrogen, et. light metal or a carboxylic acid protector. group; and z is acyloxy or heterocyclic. thio, each of the above groups u, v, w, x, y and z being optionally substituted by halogen or a carbon-, nitrogen-, oxygen- or sulfur-containing functional group.The new compounds show antibiotic action against gram-positive and gram-negative bacteria The preparation of the compounds is described.
priorityDate 1982-09-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454973655
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458396411
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID297
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID455585947
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID455502157
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559581
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID222
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419579030
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397365
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559526
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID402

Total number of triples: 40.